REDUCE-IT REVASC at #1: Top 5 Most-Read Non-COVID-19 Articles of 2020 managedhealthcareexecutive.com/view/top-5-mos… via Managed Healthcare #CardioTwitter #cardiology Ben Peterson Circulation C. Michael Gibson MD Duane Pinto MD MPH Matthew Budoff MD Ph.Gabriel Steg MICHAEL MILLER MD Christie Ballantyne

Icosapent ethyl reduced first and total coronary revascularization in pts with elevated TGs and high cardiovascular risk, despite well-controlled LDL-C on a statin ow.ly/gAUG50CZMDk #AHAJournals Ben Peterson Dr. Deepak L. Bhatt Matthew Budoff MD Ph.Gabriel Steg

Landmark analysis of the RE-DUAL PCI trial: 1.6 days avg from PCI to ASA cessation, early NCB in both dabigatran doses with dramatic early reductions in bleeding. jacc.org/doi/10.1016/j.… Dr. Deepak L. Bhatt Christopher Cannon, M.D. 🇺🇦 Ph.Gabriel Steg Brigham & Women's CV Fellows

Dropping aspirin soon after PCI seems to be the best strategy for preventing bleeding in high-risk patients with nonvalvular atrial fibrillation, according to a landmark analysis of the RE-DUAL PCI trial tctmd.com/news/dual-best… Dr. Deepak L. Bhatt Dr Roxana Mehran Davide Capodanno

Landmark analysis of RE-DUAL PCI: early net clinical benefit without increase in thrombotic events in dabigatran 150 mg + P2Y12i; ASA cessation after 1.6 days. Pleasure to work with Christopher Cannon, M.D. 🇺🇦 Dr. Deepak L. Bhatt on this! Brigham & Women's CV Fellows

The Emerging Role of Coronary Computed Tomography Angiography in Stable Angina With ISCHEMIA in @jaccjournals jacc.org/doi/10.1016/j.… Ben Peterson Sripal Bangalore Matthew Budoff MD #cardiology #cardiotwitter

CCTA for SIHD—patient selection, quality of imaging, and ongoing evaluation are all key for the “OMT alone” pathway. A pleasure writing this editorial with Dr. Deepak L. Bhatt. Brigham & Women's CV Fellows

Great job by Ben Peterson on leading this analysis from CHAMPION: Effect of Platelet Inhibition by Cangrelor Among Obese Patients Undergoing Coronary Stenting: ahajournals.org/doi/10.1161/CI… Robert Harrington Gregg W. Stone MD Ph.Gabriel Steg C. Michael Gibson MD @RenatoDLopes1 Kenneth Mahaffey #CardioTwitter

Great job by Ben Peterson on this analysis from REDUCE-IT now in JAHA - Treatment With Icosapent Ethyl Reduces Ischemic Events in Patients With Prior PCI ahajournals.org/doi/10.1161/JA… Ph.Gabriel Steg C. Michael Gibson MD MICHAEL MILLER MD Matthew Budoff MD Christie Ballantyne Duane Pinto MD MPH Dr Jean-Claude Tardif

Large reductions in CV events among patients with prior PCI treated with icosapent ethyl—NNT=12. Dr. Deepak L. Bhatt Brigham & Women's CV Fellows Ph.Gabriel Steg C. Michael Gibson MD Christie Ballantyne

Among patients with prior #PCI, icosapent ethyl reduced first events by 34% and total events by 39%. Ben Peterson @DLBhattMD #AHAJournals ahajournals.org/doi/10.1161/JA…

Six wonderful years at BWH coming to an end. Thanks to Pinak Shah, MD Piotr Dr. Deepak L. Bhatt Kevin Croce MD, PhD Ajar Kochar Brian Bergmark for the best training experience imaginable. On to the next!

Also being presented at #AHA22 by Sam Sherratt, self-funded work from the lab of Dr. Preston Mason in collaboration with Dr. Peter Libby showing, again, it's the EPA (and not the placebo choice). #cardiology #cardiotwitter ahajournals.org/doi/10.1161/ci…

It’s the EPA…. A third trial showing benefit with EPA! (The original JELIS, then REDUCE-IT, and now RESPECT EPA). lnkd.in/eyMzt5F3

It was my great pleasure to present grand rounds today at UC Cardiology. Lively and nuanced discussion about anticoagulation strategies in #AFib and #pci. Brigham & Women's CV Fellows Duke IM Residency St. Elizabeth

If you love cardiology and clinical trials, join Nicholas Marston and me as we dip our toes into the world of podcasting with “TIMI Talks”!

Intensity of Lipid-Lowering Therapy Among Patients With Polyvascular Disease | JAMA Network Open. Let’s keep chipping away at “LDL inertia” in our high-risk PVD patients. ⁦Dr. Deepak L. Bhatt⁩ ⁦Christopher Cannon, M.D. 🇺🇦⁩ ⁦St. Elizabeth⁩ ⁦⁦Amgen 🧪🔬🧬⁩ jamanetwork.com/journals/jaman…

The Thrombosis Research Group & St. Elizabeth Healthcare w/ partner Craig Janssen are excited for the launch of #AFALERT3, a cluster-randomized, 2500-patient trial of advanced alert-based computerized decision support to improve stroke prevention in high-risk patients with #AF.